Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 181

    1.

    Bridging low-molecular-weight heparin for temporary interruption of warfarin.

    Shojania AM.

    Ann Intern Med. 2007 Nov 6;147(9):671; author reply 671. No abstract available. PMID: 17975192 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Brief communication: Preoperative anticoagulant activity after bridging low-molecular-weight heparin for temporary interruption of warfarin.

    O'Donnell MJ, Kearon C, Johnson J, Robinson M, Zondag M, Turpie I, Turpie AG.

    Ann Intern Med. 2007 Feb 6;146(3):184-7.PMID: 17283349 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Summaries for patients. Safety of surgery during bridging anticoagulation therapy with low-molecular-weight heparin.

    [No authors listed]

    Ann Intern Med. 2007 Feb 6;146(3):I35. No abstract available. PMID: 17283344 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Single-arm study of bridging therapy with low-molecular-weight heparin for patients at risk of arterial embolism who require temporary interruption of warfarin.

    Kovacs MJ, Kearon C, Rodger M, Anderson DR, Turpie AG, Bates SM, Desjardins L, Douketis J, Kahn SR, Solymoss S, Wells PS.

    Circulation. 2004 Sep 21;110(12):1658-63. Epub 2004 Sep 13.PMID: 15364803 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Warfarin cessation before cardiopulmonary bypass: lessons learned from a randomized controlled trial of oral vitamin K.

    Whitlock RP, Crowther MA, Warkentin TE, Blackall MH, Farrokhyar F, Teoh KH.

    Ann Thorac Surg. 2007 Jul;84(1):103-8.PMID: 17588394 [PubMed - indexed for MEDLINE]Related articles

    6.

    Surgical delay in acute admissions on warfarin: are we doing enough?

    Tharmarajah P.

    Int J Clin Pract. 2007 Jul;61(7):1233. No abstract available. PMID: 17577302 [PubMed - indexed for MEDLINE]Related articles

    7.

    Bridging anticoagulation with low-molecular-weight heparin after interruption of warfarin therapy is associated with a residual anticoagulant effect prior to surgery.

    Douketis JD, Woods K, Foster GA, Crowther MA.

    Thromb Haemost. 2005 Sep;94(3):528-31.PMID: 16268467 [PubMed - indexed for MEDLINE]Related articles

    8.

    Oral vitamin K produces a normal INR within 24 hours of its administration in most patients discontinuing warfarin.

    Crowther MA, Ageno W, Schnurr T, Manfredi E, Kinnon K, Garcia D, Douketis JD.

    Haematologica. 2005 Jan;90(1):137-9.PMID: 15642685 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment.

    Nagge J, Fernandes O, Huh J.

    Am Heart J. 2005 Mar;149(3):e21; author reply e23-4. No abstract available. PMID: 15864222 [PubMed - indexed for MEDLINE]Related articles

    10.

    Low-dose oral vitamin K to normalize the international normalized ratio prior to surgery in patients who require temporary interruption of warfarin.

    Woods K, Douketis JD, Kathirgamanathan K, Yi Q, Crowther MA.

    J Thromb Thrombolysis. 2007 Oct;24(2):93-7. Epub 2007 Mar 23.PMID: 17380255 [PubMed - indexed for MEDLINE]Related articles

    11.

    Retrospective evaluation of a pharmacokinetic program for adjusting enoxaparin in renal impairment.

    Kruse MW, Lee JJ.

    Am Heart J. 2004 Oct;148(4):582-9.PMID: 15459586 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Perioperative Bridging with Enoxaparin. Results of the Prospective BRAVE Registry with 779 Patients]

    Omran H, Hammerstingl C, Paar WD; Bonn Registry of Alternative Anticoagulation to Prevent Vascular Events.

    Med Klin (Munich). 2007 Oct 15;102(10):809-15. German. PMID: 17928964 [PubMed - indexed for MEDLINE]Related articles

    13.

    Pulmonary delivery of low molecular weight heparins.

    Yang T, Mustafa F, Bai S, Ahsan F.

    Pharm Res. 2004 Nov;21(11):2009-16.PMID: 15587922 [PubMed - indexed for MEDLINE]Related articles

    14.

    Seaweed, vitamin K, and warfarin.

    Bartle WR, Madorin P, Ferland G.

    Am J Health Syst Pharm. 2001 Dec 1;58(23):2300. No abstract available. PMID: 11763808 [PubMed - indexed for MEDLINE]Related articles

    15.

    Warfarin or low-molecular-weight heparin therapy does not prolong pig-to-primate cardiac xenograft function.

    Byrne GW, Schirmer JM, Fass DN, Teotia SS, Kremers WK, Xu H, Naziruddin B, Tazelaar HD, Logan JS, McGregor CG.

    Am J Transplant. 2005 May;5(5):1011-20.PMID: 15816881 [PubMed - indexed for MEDLINE]Related articles

    16.

    Complexation of a poly-L-arginine with low molecular weight heparin enhances pulmonary absorption of the drug.

    Rawat A, Yang T, Hussain A, Ahsan F.

    Pharm Res. 2008 Apr;25(4):936-48. Epub 2007 Oct 23.PMID: 17955186 [PubMed - indexed for MEDLINE]Related articles

    18.

    Risk of thromboembolism with short-term interruption of warfarin therapy.

    Garcia DA, Regan S, Henault LE, Upadhyay A, Baker J, Othman M, Hylek EM.

    Arch Intern Med. 2008 Jan 14;168(1):63-9.PMID: 18195197 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Vitamin K-independent warfarin resistance after concurrent administration of warfarin and continuous enteral nutrition.

    Dickerson RN, Garmon WM, Kuhl DA, Minard G, Brown RO.

    Pharmacotherapy. 2008 Mar;28(3):308-13.PMID: 18294110 [PubMed - indexed for MEDLINE]Related articles

    20.

    Why warfarin and heparin need to overlap when treating acute venous thromboembolism.

    Wittkowsky AK.

    Dis Mon. 2005 Feb-Mar;51(2-3):112-5. No abstract available. PMID: 15900262 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data